TY - JOUR KW - Adaptor Proteins, Signal Transducing KW - Amino Acid Sequence KW - Antibodies, Monoclonal KW - Antigens, Bacterial KW - CTLA-4 Antigen KW - Cell Lineage KW - Cell Wall KW - Cells, Cultured KW - Cytokines KW - Disease Progression KW - Gene Expression Profiling KW - Gene Expression Regulation KW - Humans KW - Immune Tolerance KW - Immunity, Cellular KW - Leprosy, Multibacillary KW - Leprosy, Paucibacillary KW - Molecular Sequence Data KW - Mycobacterium leprae KW - Proto-Oncogene Proteins c-cbl KW - RNA, Small Interfering KW - T-Lymphocytes, Regulatory KW - Th1 Cells KW - Th2 Cells KW - Transforming Growth Factor beta AU - Kumar S AU - Naqvi R AU - Khanna N AU - Pathak P AU - Rao D N AB -
Leprosy is a chronic human disease; primarily affecting skin, peripheral nerves, eyes, testis etc. Comprehensive-expressional-profiling of Th1-Th2-Th3 associated markers (84 genes) using qRT-PCR array, negated the previously prevailing notion, Th2 bias towards multibacillary stage of leprosy. High production TGF-β further supported the dearth of any immune response(s) in leprosy progression. Over expression of Cbl-b, could emerge as plausible reason for contributing T cell hyporesponsiveness, possibly by degradation of T cells signaling molecules. Anti-TGF-β treatments further confirm the TGF-β-dependent-Cbl-b overexpression in multibacillary patients. Diminished Cbl-b expression in CTLA-4 knockout studies using siRNA, provided other evidence towards T cell hyporesponsiveness. Further, high T cell proliferation and IL-2 production in PBMC cultures treated with anti-TGF-β and siRNA offers here a strategy to revert T cell hyporesponsiveness by downregulating Cbl-b expression in leprosy. Thus, this study negates Th2 bias and substantiates molecular cross-talk amongst TGF-β-CTLA-4-Cbl-b eventually leads to M. leprae persistence.
BT - Clinical immunology (Orlando, Fla.) C1 - http://www.ncbi.nlm.nih.gov/pubmed/21807564?dopt=Abstract DA - 2011 Nov DO - 10.1016/j.clim.2011.06.007 IS - 2 J2 - Clin. Immunol. LA - eng N2 -Leprosy is a chronic human disease; primarily affecting skin, peripheral nerves, eyes, testis etc. Comprehensive-expressional-profiling of Th1-Th2-Th3 associated markers (84 genes) using qRT-PCR array, negated the previously prevailing notion, Th2 bias towards multibacillary stage of leprosy. High production TGF-β further supported the dearth of any immune response(s) in leprosy progression. Over expression of Cbl-b, could emerge as plausible reason for contributing T cell hyporesponsiveness, possibly by degradation of T cells signaling molecules. Anti-TGF-β treatments further confirm the TGF-β-dependent-Cbl-b overexpression in multibacillary patients. Diminished Cbl-b expression in CTLA-4 knockout studies using siRNA, provided other evidence towards T cell hyporesponsiveness. Further, high T cell proliferation and IL-2 production in PBMC cultures treated with anti-TGF-β and siRNA offers here a strategy to revert T cell hyporesponsiveness by downregulating Cbl-b expression in leprosy. Thus, this study negates Th2 bias and substantiates molecular cross-talk amongst TGF-β-CTLA-4-Cbl-b eventually leads to M. leprae persistence.
PY - 2011 SP - 133 EP - 42 T2 - Clinical immunology (Orlando, Fla.) TI - Th3 immune responses in the progression of leprosy via molecular cross-talks of TGF-β, CTLA-4 and Cbl-b. VL - 141 SN - 1521-7035 ER -